Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)
- Sumitra Thongprasert
- , Emma Duffield
- , Nagahiro Saijo
- , Yi Long Wu
- , James Chih Hsin Yang
- , Da Tong Chu
- , Meilin Liao
- , Yuh Min Chen
- , Han Pin Kuo
- , Shunichi Negoro
- , Kwok Chi Lam
- , Alison Armour
- , Patrick Magill
- , Masahiro Fukuoka
Research output: Contribution to journal › Article › peer-review
129
Link opens in a new tab
Citations
(Scopus)